24 records – page 1 of 2.

Select Title Policy Type Year
EspAddText
EspRemoveText
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations Response to consultation 2014
EspAddText
EspRemoveText
Proposed amendments to the marihuana for medical purposes regulations Response to consultation 2014
EspAddText
EspRemoveText
Tamper Resistance under the Controlled Drugs and Substances Act Response to consultation 2014
EspAddText
EspRemoveText
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) Response to consultation 2015
EspAddText
EspRemoveText
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions. Response to consultation 2016
EspAddText
EspRemoveText
Consultation on the prescription drug list: Naloxone Response to consultation 2016
EspAddText
EspRemoveText
Legalization, regulation and restriction of access to marijuana Response to consultation 2016
EspAddText
EspRemoveText
CMA response to patented medicines regulations consultations Response to consultation 2017
EspAddText
EspRemoveText
Non-prescription availability of low-dose codeine products Response to consultation 2017
EspAddText
EspRemoveText
Excise duty framework for cannabis products Response to consultation 2017
EspAddText
EspRemoveText
Regulation of Self-Care Products in Canada Response to consultation 2016
EspAddText
EspRemoveText
Consultation on the renewal of Federal Tobacco Control Strategy Response to consultation 2017
EspAddText
EspRemoveText
Health Canada’s Consultation on “Plain and Standardized Packaging” Response to consultation 2016
EspAddText
EspRemoveText
Proposed approach to the regulation of cannabis Response to consultation 2018
EspAddText
EspRemoveText
Federal Monitoring and Reporting Regime for MAID Response to consultation 2017
EspAddText
EspRemoveText
Federal monitoring of medical assistance in dying regulations Response to consultation 2018
EspAddText
EspRemoveText
Consultation on proposed front-of-package labelling Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on restriction of marketing and advertising of opioids Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on regulatory amendments regarding tramadol Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on tobacco products regulations (plain and standardized appearance) Response to consultation 2018

24 records – page 1 of 2.